Before completing an order, check the product name, quantity and any additional choices
Deep learning predicts HER2 status in invasive breast cancer from multimodal ultrasound and MRI
Safety: what we know, what we dont What clinical trial safety reviews suggest The clinical safety review literature reports several reassuring signals: No meaningful increase in IGF-1 in monitored long-term studies (jofem.org) No clear negative effect on carbohydrate metabolism in testing described (contrast with full hGH) (jofem.org) No clear immunogenicity signal (e.g., anti-AOD antibodies) in the subset assessed in those trials (jofem.org) The major limitation: long-term real-world certainty is thin The problem with many peptides is not that everything is dangerousits that the certainty level is often lower than patients assume
While theres no direct evidence linking compounds like BPC-157 or TB500 to cancer, researchers emphasise that the long-term effects remain unknown because these substances have never undergone proper human trials
The interest has helped fuel a grey market where consumers seek access to research-grade injections, including experimental weight-loss therapies such as retatrutide
Blocking GABA A receptors enhanced network activity and resulted in an increase in glutamatergic excitatory inputs (Fig